SERENDIP INNOVATIONS Trademark

Trademark Overview


On Friday, November 15, 2024, a trademark application was filed for SERENDIP INNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the SERENDIP INNOVATIONS trademark a serial number of 79414532. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Saturday, January 17, 2026. This trademark is owned by Serendip Innovations SAS. The SERENDIP INNOVATIONS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Research and development services in the field of chemistry, biology and biochemistry; Research and development services in the field of oncology; Research and development services in the field of cancerous diseases; Research and development services in the field of immunology; Research and development services in the field of vaccinology; Research and development services in the field of bacteriology and virology; Research and development services in the field of antibody technology; Research and development in the field of antibodies; Research and development services in the field of animal health; Technical project study services being scientific research services in the field of chemistry, biology and biochemistry; Technical project study services being scientific research services in oncology, immunology and vaccinology; Biological research; Research in bacteriology and virology; Technical project study services being scientific research services in the field of animal health; Res...

Medicines for human medicine designed based on the enhanced VLP (virus-like particle) technology; Anti-cancer medicines; Immunosuppressive medicines; Immunomodulator medicines for treating autoimmune diseases, cancer, infections; Anti-inflammatory medications; Tonics being medicines designed based on the enhanced VLP (virus-like particle) technology; Vaccines; Vaccines for human use; Vaccines for the treatment of cancer; Cellular function activating agents for medical purposes; Biopharmaceutical products for cancer treatment; Pharmaceutical preparations for use in oncology for cancer treatment; Pharmaceuticals for the treatment of inflammatory diseases, namely, anti- inflammatories; Biological preparations for the treatment of cancer; Immunotherapeutic agents for bacterial infections; Immune modulators being pharmaceutical preparations for the treatment of immune system related diseases and disorders; Immunostimulants; Pharmaceuticals for use in the treatment of diseases and disorders ...
serendip innovations

General Information


Serial Number79414532
Word MarkSERENDIP INNOVATIONS
Filing DateFriday, November 15, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateSaturday, January 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"INNOVATIONS"
Goods and ServicesResearch and development services in the field of chemistry, biology and biochemistry; Research and development services in the field of oncology; Research and development services in the field of cancerous diseases; Research and development services in the field of immunology; Research and development services in the field of vaccinology; Research and development services in the field of bacteriology and virology; Research and development services in the field of antibody technology; Research and development in the field of antibodies; Research and development services in the field of animal health; Technical project study services being scientific research services in the field of chemistry, biology and biochemistry; Technical project study services being scientific research services in oncology, immunology and vaccinology; Biological research; Research in bacteriology and virology; Technical project study services being scientific research services in the field of animal health; Research in chemistry, biology and biochemistry; Research in oncology, immunology and vaccinology; Scientific research conducted using databases; Scientific research for medical purposes in the field of oncology; Scientific research for medical purposes in the field of cancerous diseases; Scientific research for medical purposes in the field of immunology; Scientific research for medical purposes in the field of vaccinology; Scientific research for medical purposes in the field of virology and bacteriology; Technical research in the field of therapeutic candidates design, screening, development, production and quality control testing; Chemical, biological and biochemical technology research; Technical writing; Chemistry, biology and biochemistry services, namely, design, screening, development, production and quality control testing of therapeutic candidates; Scientific laboratory services; Scientific research services; Scientific research services for medical purposes; Research laboratory services; Research and development in the field of biotechnology; Research and development in the field of oncology, immunology and vaccinology; Scientific testing of drug substances and drug products; Scientific research in the nature of carrying out clinical trials for others; Scientific services, namely, design, screening, development, production and quality control testing of therapeutic candidates; Scientific design services, namely, therapeutic candidates design and production processes; Advisory services relating to research and development in the field of therapeutics; Medicine discovery services; Development of pharmaceutical preparations and medicines; Developing gene-based, antigen-based medicines; Research and development of vaccines and medicines; Research and development services with respect to vaccines; Research and development of medicines; Research and development of siRNA-based medicines; Providing medical and scientific research information in the field of clinical trials, namely, provision of medical and scientific research information concerning the results of clinical trials for pharmaceutical products; Provision of information relating to medical preparations research and development; Research laboratory analysis services in the field of chemistry, biology and biochemistry; Scientific research; Scientific analysis, namely, chemical analysis biological analysis; Conducting of technical project studies being scientific research and development services; Providing scientific research services; Preparing project analysis studies, namely, conducting scientific feasibility studies; Preparation of technical surveys being technical surveying services; Scientific research and development, namely, preparation of reports concerning scientific research; Scientific research and development, namely, preparation of scientific reports; Carrying out technical scientific feasibility studies; Research in the field of bioengineering; Information service concerning scientific research; Scientific information service, namely, providing scientific information in the field of design, screening, development, production and quality control testing of therapeutic candidates; Industrial analysis and research services in the field of chemistry, biology and biochemistry; Laboratory testing services for testing of materials; Consultant services in the field of scientific research; Advice relating to scientific research; Scientific research and development advisory services; Human and animal health medicine discovery services; Development of testing methods, namely, development and establishment of testing specifications and procedures for the pharmaceutical industry; Vaccine discovery services
Goods and ServicesMedicines for human medicine designed based on the enhanced VLP (virus-like particle) technology; Anti-cancer medicines; Immunosuppressive medicines; Immunomodulator medicines for treating autoimmune diseases, cancer, infections; Anti-inflammatory medications; Tonics being medicines designed based on the enhanced VLP (virus-like particle) technology; Vaccines; Vaccines for human use; Vaccines for the treatment of cancer; Cellular function activating agents for medical purposes; Biopharmaceutical products for cancer treatment; Pharmaceutical preparations for use in oncology for cancer treatment; Pharmaceuticals for the treatment of inflammatory diseases, namely, anti- inflammatories; Biological preparations for the treatment of cancer; Immunotherapeutic agents for bacterial infections; Immune modulators being pharmaceutical preparations for the treatment of immune system related diseases and disorders; Immunostimulants; Pharmaceuticals for use in the treatment of diseases and disorders in the fields of oncology, immunology, intensive therapeutic assets medicine, and organ transplantation medicine; Pharmaceuticals for influencing the immune system for treatment of autoimmune diseases, cancer, infections; Pharmaceuticals for the prevention and treatment of viral diseases, namely, vaccines against infectious diseases and viral infections; Pharmaceuticals for the treatment of diseases of the immune system; Pharmaceuticals for the treatment of oncological diseases; Biological preparations for medical use for treating autoimmune diseases, cancer, infections; Mixed biological preparations for medical use for treating autoimmune diseases, cancer, infections; Biochemical preparations for medical use for treating autoimmune diseases, cancer, infections; Chemical-pharmaceutical preparations for treating autoimmune diseases, cancer, infections; chemical preparations for medical use for treating autoimmune diseases, cancer, infections; Phytotherapy preparations for medical use; Diagnostic preparations for medical use; Medical and pharmaceutical substances and preparations used in oncology; Medical and pharmaceutical substances and preparations used in immunology; Reagents for medical use; Chemical reagents for medical use; Diagnostic biomarking reagents for medical use; Anti-inflammatories; Antibiotics
Pseudo MarkSEREN DIP INNOVATIONS; SERENDIPITY INNOVATIONS; SERENDIPITOUS INNOVATIONS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSerendip Innovations SAS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 9, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, January 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, January 12, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, April 23, 2025ASSIGNED TO EXAMINER
Tuesday, April 29, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 30, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 1, 2025REFUSAL PROCESSED BY MPU
Tuesday, July 1, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 19, 2025REFUSAL PROCESSED BY IB
Wednesday, December 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 17, 2026SUSPENSION LETTER WRITTEN
Saturday, January 17, 2026LETTER OF SUSPENSION E-MAILED
Saturday, January 17, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED